Literature DB >> 29764780

What is the Required Frequency of MRI Scanning in the Wait and Scan Management?

Thomas Somers1, Romain Kania2, Jerome Waterval3, Tony Van Havenbergh4.   

Abstract

The wait and scan policy is being increasingly used as the first measure after the diagnosis of a vestibular schwannoma (VS) using magnetic resonance imaging (MRI). As part of the European Academy of Otology and Neuro-Otology (EAONO) position statement on VS, the frequency of imaging has been studied in the literature. Among 163 studies, 29 fulfilled the inclusion criteria and were scored using the Grading of Recommendations, Assessment, Development, and Evaluation system. Because tumor growth rate during the first 5 years of follow-up is predictive of further growth during the upcoming years, a protocol for wait and scan is useful for centers dealing with this condition. The EAONO proposal is that after the initial diagnosis by MRI, a first new MRI would take place after 6 months, annually for 5 years, and then every other year for 4 years, followed by a lifelong MRI follow-up every 5 years. The first early MRI is to screen for fast-growing tumors, and the lifelong follow-up with tapered intervals is to detect late repeated growth.

Entities:  

Mesh:

Year:  2018        PMID: 29764780      PMCID: PMC6354487          DOI: 10.5152/iao.2018.5348

Source DB:  PubMed          Journal:  J Int Adv Otol        ISSN: 1308-7649            Impact factor:   1.017


  29 in total

1.  The natural history of vestibular schwannoma.

Authors:  Sven-Eric Stangerup; Per Caye-Thomasen; Mirko Tos; Jens Thomsen
Journal:  Otol Neurotol       Date:  2006-06       Impact factor: 2.311

2.  Conservative management versus surgery for small vestibular schwannomas.

Authors:  Alexis Bozorg Grayeli; Michel Kalamarides; Evelyne Ferrary; Didier Bouccara; Hani El Gharem; Alain Rey; Olivier Sterkers
Journal:  Acta Otolaryngol       Date:  2005-10       Impact factor: 1.494

Review 3.  Systematic review of the natural history of vestibular schwannoma.

Authors:  Yuhei Yoshimoto
Journal:  J Neurosurg       Date:  2005-07       Impact factor: 5.115

4.  Effectiveness of conservative management of acoustic neuromas.

Authors:  Y J Shin; B Fraysse; C Cognard; I Gafsi; J P Charlet; C Berges; O Deguine; M Tremoulet
Journal:  Am J Otol       Date:  2000-11

5.  Acoustic neuromas in the elderly.

Authors:  B P Perry; B J Gantz; J T Rubinstein
Journal:  Otol Neurotol       Date:  2001-05       Impact factor: 2.311

Review 6.  Comparison of growth patterns of acoustic neuromas with and without radiosurgery.

Authors:  Alex Battaglia; Bill Mastrodimos; Roberto Cueva
Journal:  Otol Neurotol       Date:  2006-08       Impact factor: 2.311

Review 7.  Natural history of acoustic neuromas.

Authors:  S I Rosenberg
Journal:  Laryngoscope       Date:  2000-04       Impact factor: 3.325

8.  Conservative management of acoustic neuroma.

Authors:  Abdulrahman Al Sanosi; Paul A Fagan; Nigel D W Biggs
Journal:  Skull Base       Date:  2006-05

9.  Conservative management of vestibular schwannomas - second review of a prospective longitudinal study.

Authors:  V V Raut; R M Walsh; A P Bath; M L Bance; A Guha; C H Tator; J A Rutka
Journal:  Clin Otolaryngol Allied Sci       Date:  2004-10

10.  Conservative management of vestibular schwannomas: an effective strategy.

Authors:  Gian Gaetano Ferri; Giovanni Carlo Modugno; Antonio Pirodda; Antonio Fioravanti; Fabio Calbucci; Alberto Rinaldi Ceroni
Journal:  Laryngoscope       Date:  2008-06       Impact factor: 3.325

View more
  2 in total

Review 1.  Evaluating growth trends of residual sporadic vestibular schwannomas: a systematic review and meta-analysis.

Authors:  Abdullah Egiz; Hritik Nautiyal; Andrew F Alalade; Nihal Gurusinghe; Gareth Roberts
Journal:  J Neurooncol       Date:  2022-06-27       Impact factor: 4.506

Review 2.  Understanding the Molecular Mechanism of Vestibular Schwannoma for Hearing Preservation Surgery: Otologists' Perspective from Bedside to Bench.

Authors:  Makoto Hosoya; Takeshi Wakabayashi; Koichiro Wasano; Takanori Nishiyama; Nobuyoshi Tsuzuki; Naoki Oishi
Journal:  Diagnostics (Basel)       Date:  2022-04-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.